Background: Atrial tachycardia-induced remodeling promotes the occurrence and maintenance of atrial fibrillation (AF) and decreases promoting effect of Ca channel inhibition. Methods: To evaluate the potential mechanisms of AF promotion by Ca channel blockers, we administered verapamil to morphine-chloralose anesthetized dogs. Diltiazem was used as a comparison drug and autonomic blockade with atropine and nadolol was applied in some experiments. Epicardial mapping with 240 epicardial electrodes was used to evaluate activation during AF. Results: Verapamil caused AF promotion in six dogs, increasing mean duration of AF induced by burst pacing, from 864 s (mean6S.E.) to 95639 s (P,0.01 vs. control) at a loading dose of 0.1 mg / kg and 2286101 s (P,0.0005 vs. control) at a dose of 0.2 mg / kg. Underlying electrophysiological mechanisms were studied in detail in five additional dogs under control conditions and in the presence of the higher dose of verapamil. In these experiments, verapamil shortened mean effective refractory period (ERP) from 12265 to 11464 ms (P,0.02) at a cycle length of 300 ms, decreased ERP heterogeneity (from 1561 to 1061%, P,0.05), heterogeneously accelerated atrial conduction and decreased the cycle length of AF (9464 to 8463 ms, P,0.005). Diltiazem did not affect ERP, AF cycle length or AF duration, but produced conduction acceleration similar to that caused by verapamil (n55). In the presence of autonomic blockade, verapamil failed to promote AF and increased, rather than decreasing, refractoriness. Neither verapamil nor diltiazem affected atrial conduction in the presence of autonomic blockade. Epicardial mapping suggested that verapamil promoted AF by increasing the number of simultaneous wavefronts reflected by separate zones of reactivation in each cycle. Conclusions: Verapamil promotes AF in normal dogs by promoting multiple circuit reentry, an effect dependent on intact autonomic tone and not shared by diltiazem.
Introduction
prevent thromboembolic complications with oral anticoagulants [3] . Among the drugs used to control the ventricu- 21 Atrial fibrillation (AF) is presently the most common lar response rate are inhibitors of L-type Ca current such sustained cardiac arrhythmia in clinical practice, and its as diltiazem and verapamil. There is, however, clinical 21 treatment is less than optimal in many cases [1] . Antiarevidence that Ca channel blockers such as verapamil and rhythmic drugs improve sinus rhythm maintenance, but at diltiazem may promote AF maintenance [4] . Two recent 21 the expense of a variety of potential adverse effects, of experimental studies also suggest that the Ca channel which one of the most worrisome is ventricular proarblocker verapamil may promote experimental AF. Lee et rhythmia [2] . An alternative approach is to leave patients al. showed that verapamil administration during a 7-42 in AF, but to control the ventricular response and to day period of atrial tachycardia and at the time of a subsequent electrophysiological study fails to prevent tachycardia-induced remodeling and promotes AF mainte-nance during the electrophysiological study [5] . Friedman et al. showed that verapamil promotes AF maintenance in anesthetized dogs, an effect that can be prevented by b-adrenoceptor blockade [6] . Neither study evaluated the electrophysiological mechanisms potentially underlying verapamil's apparent AF promoting action. The present study was designed to (1) determine whether verapamil increases AF duration in the anesthetized dog in a dose related fashion; (2) evaluate potential underlying mechanisms by measuring atrial effective refractory period (ERP) and conduction velocity, as well as by studying changes in activation during AF with the use of atrial 21 epicardial mapping; and (3) determine whether the Ca channel blocker diltiazem shares verapamil's AF promoting potential. 
Methods
Stimulation sites for conduction measurements are indicated by haloed dots. Arrows indicate the series of electrodes used for conduction velocity
Animal preparation
analysis in each zone. AVR, atrio-ventricular ring; RFW, right free wall; IVC, SVC, inferior, superior vena cava; PV, pulmonary vein; LPW, left Twenty-five mongrel dogs (2761 kg) were studied in posterior wall.
four groups: (1) Group 1: a dose-response group (n56), in which the effects of verapamil on AF duration were studied at two dose levels (0.1 and 0.2 mg / kg loading previously described in detail [7, 8] . A mapping system was doses, followed by maintenance infusions of 0.5 and 1.5 connected to five arrays covering the atrial epicardial mg / kg / min infusions, respectively); (2) Group 2: a desurfaces with 240 bipolar electrodes ( Fig. 1) as previously tailed electrophysiology group (n55), in which the electrodescribed. Signals were filtered (bandwidth of 10-900 Hz), physiological effects of verapamil were studied at a single, digitized (12-bit resolution and 2-kHz sampling rate), and high loading dose (0.2 mg / kg, followed by 1.5 mg / kg / transmitted into a Silicon Graphics computer for analysis. min); (3) Group 3: a diltiazem group (n55), in which the Activation data were analyzed off line with computer effects of diltiazem (0.8 mg / kg, followed by 15 mg / kg / determined peak-amplitude criteria for activation, and data min) were studied; and (4) Group 4: an autonomic for each electrode were reviewed manually. Atrial ERP blockade group, in which the effects of verapamil (n55) (longest coupling interval at which premature electrical and diltiazem (n54) were studied in the presence of extrastimuli failed to capture) and conduction velocity pharmacological blockade of cardiac b-adrenergic and were measured during stimulation at sites in various atrial muscarinic cholinergic receptors.
regions as in previous work [7, 8] . Activation maps for Animal handling procedures followed the guidelines of conduction measurement were obtained after 60 s at a the Canadian Council on Animal Care, and were approved variety of basic cycle lengths. Conduction velocity was by the institutional animal research ethics committee. On measured with the use of two parallel sets of four the study day, dogs were anesthetized with morphine (2 electrodes during local pacing in each of four regions: the mg / kg s.c.) and a-chloralose (120 mg / kg i.v. load, 29.3 left atrial appendage, the right atrial appendage, the right 21 mg / kg h ) and ventilated to maintain physiological superior free wall and the right inferior free wall (Fig. 1) . arterial blood gases (pH 7.38-7.45, SaO .90%). Body
Because of variable contact in the left atrium, complete 2 temperature was maintained at 378C and a femoral artery conduction data were only available at right atrial sites. To and both femoral veins were cannulated for arterial blood measure ERP, a 15 stimulus basic train (2-ms twice pressure monitoring and drug administration. A median threshold current pulses) was followed by a premature sternotomy was performed and bipolar PTFE coated extrastimulus at a progressively increasing coupling interstainless electrodes hooked into right and left atrial appenval and a 2-s pause to observe the response between trains. dages for stimulation and recording. The surface ECG was
The premature coupling interval was increased by 10-ms monitored and epicardial mapping arrays sewn to the increments to obtain an initial estimate of the ERP. The epicardial surfaces of both atria. measurement was then repeated with 5-ms increments and the resulting value taken as the ERP. In the case of a 2.2. Electrophysiological study .10-ms difference between the two measurements, a third measurement with 5-ms steps was obtained and the mean The study preparation and instrumentation were as of all three ERP values was used. This protocol was used to measure ERPs at cycle lengths of 150, 200, 250, 300 2.4. Data analysis and 350 ms at the right atrial appendage, and to measure ERPs during stimulation at a single pacing cycle length
The conduction velocity was determined in each region (300 ms) at 2362 right and left atrial sites.
as previously described. The coefficient of variance in ERP AF was induced by stimulating the right atrial appenwas calculated as S.D. / mean3100% and used as an index dage with 10 Hz, 2 ms stimuli at four times threshold of ERP heterogeneity. The number of sites for ERP current for 2-10 s. To calculate mean AF duration, AF determination in each region was equivalent across dogs was induced with burst pacing ten times for AF duration and between groups, to prevent any selection bias. Statisti-,10 min and twice for AF duration .10 min. AF that cal comparisons between two groups only were performed lasted .20 min, requiring electrical cardioversion for by Student's t test. Analysis of variance with a range test termination, was considered persistent. A 20-min rest was used for multiple group comparisons. Average results period was allowed before continuing the experiment.
are given as the mean6S.E.M., and a two-tailed P,0.05 was considered statistically significant.
Pharmacological study 3. Results
Verapamil and diltiazem were dissolved in 0.9% saline the day of the experiment and were kept at 48C until 15 3.1. Dose related effects of verapamil min before use. In the first part of the study (Group 1), we tested two intravenous doses of verapamil hydrochloride
The dose related effects of verapamil observed in Group (Sigma): first dose: a loading infusion of 0.10 mg / kg over 1 dogs are summarized in Table 1 . Verapamil slightly, but 10 min, followed by a maintenance dose of 0.5 mg / kg / min non-significantly, increased sinus cycle length, while causfor the time needed to complete electrophysiological ing clear, dose related decreases in arterial pressure. The measurements (|30-45 min); second dose: load of 0.20 PR interval was also increased by the drug, with other mg / kg, i.v.) followed by a maintenance infusion of 1.5 ECG intervals unaffected. AF duration was clearly inmg / kg / min. In each case, measurements were begun 10 creased in a dose related fashion. min after the completion of the loading dose. These doses were based on previously published data showing signifi-3.2. Electrophysiological mechanisms of AF promotion cant and stable pharmacological actions and plasma conby verapamil centrations [9] . We then pursued more detailed electrophysiological evaluations with the higher dose only (Group In order to assess the mechanism by which verapamil 2 dogs). We then studied a group of dogs receiving promotes AF, we performed epicardial mapping during AF diltiazem (Sigma) at the highest dose shown in a previous under control conditions and in the presence of the higher multiple dose study [9] to be tolerated and produce stable dose of verapamil (Group 2 dogs). The general effects of electrophysiological effects in the dog (loading dose 0.8 verapamil in Group 2 dogs are shown in Table 2 . As in mg / kg, followed by 15 mg / kg / min maintenance infusion).
Group 1 dogs, 0.2 mg / kg verapamil slightly (but nonsigIn a final group (Group 4), the effects of the higher dose of nificantly) prolonged sinus cycle length, reduced arterial verapamil and of diltiazem were studied in the presence of pressure, and significantly increased both PR interval and autonomic blockade produced with nadolol (0.5 mg / kg, AF duration. The results of mapping studies are illustrated followed by an additional 0.25 mg / kg every 2 h) and in Fig. 2 , which shows activation during three consecutive atropine (1 mg every 2 h).
cycles under control conditions ( Fig. 2A ) and in the presence of verapamil (Fig. 2B) . Isochrone maps (20-ms) are shown, with the activation times indicated all referenced to the earliest activation in the first cycle. Solid arrows represent the direction of impulse propagation and solid lines, zones of functional block (.40 ms activation time differences between adjacent electrodes). Regions that are not activated within a cycle are designated by 3s. The dashed lines indicate probable paths of reactivation initiating the next cycle. Under control conditions ( Fig. 2A) , activation is relatively homogeneous, with approximately two discrete zones of reactivation (indicated by the asterisks) per cycle. In the presence of verapamil, activation is more heterogeneous. There are more zones of functional block, more apparent reentry circuits and more zones of reactivation at the beginning of each cycle. Fig. 3A shows mean data for the number of reactivation zones per cycle, based on measurements for three consecutive cycles under each condition in each dog. Verapamil clearly increased the number of reactivation zones considerably, from just over one to almost three / cycle. Thus, verapamil's ability to promote AF is likely related to the promotion of multiple wavelet reentry by decreasing the size and increasing the number of functional reentry circuits during the arrhythmia.
In order to explore further the electrophysiological mechanisms underlying verapamil's AF promoting action, we assessed drug-induced changes in atrial refractoriness and conduction properties. ERP at the right atrial appendix is shown as a function of cycle length in Fig. 4A . Verapamil tended to decrease ERP slightly but not significantly at long cycle lengths, with no change at short cycle lengths. Fig. 4B shows mean ERP data from all sites at a cycle length of 300 ms, and indicates that verapamil slightly but significantly decreased ERP. Verapamil-induced changes in AF cycle length are shown in Fig. 4C , which indicates that the drug significantly decreased the mean cycle length during AF, consistent with the ERP changes. ERP and conduction, mean reentrant wavelength was unaffected by the drug (11.060.6 cm before and 11.360.5 cm after verapamil administration).
Effects of diltiazem on atrial electrophysiology and AF
To determine whether diltiazem shares verapamil's actions on atrial electrophysiology and arrhythmias, we studied the effects of the drug in Group 3 dogs. Like high dose verapamil, diltiazem decreased arterial pressure and increased the PR interval (Table 2) . Unlike verapamil, diltiazem did not significantly alter AF duration. Diltiazem did not alter atrial ERP, which averaged 11262 ms at all sites (cycle length 300 ms) before diltiazem and 11663 ms after the drug. Similarly, AF cycle length was not affected by diltiazem (9463 ms control, 9263 ms drug, P5NS). Diltiazem did produce significant increases in conduction velocity, with a spatial distribution similar to those caused by verapamil (Fig. 6, right) . Thus, despite similar effects on blood pressure, PR interval and intra-atrial conduction, diltiazem did not share verapamil's ability to decrease atrial ERP or AF cycle length and did not promote AF.
Effects of verapamil and diltiazem in the presence of autonomic blockade
In order to evaluate effects of verapamil and diltiazem in the absence of autonomic reflexes, we studied Group 4 dogs in the presence of b-adrenergic and muscarinic receptor blockade. In the presence of autonomic blockade, verapamil reduced arterial pressure and increased the PR interval, but did not affect AF duration (Table 3 , Fig. 7A ). Typical activation maps for AF in the presence of verapamil and autonomic blockade are shown in Fig. 2C , and indicate that under these conditions activation was relatively homogeneous and there were few reactivation zones intact autonomic reflexes, verapamil significantly increased AF cycle length in the presence of autonomic blockade nificantly the shortest ERP value for all sites in each dog (Fig. 7B ) and slightly but significantly increased ERP (Fig.  (Fig. 5A ), but substantially decreased the maximum value 7C) without affecting ERP heterogeneity (Fig. 7D) . Unlike (Fig. 5B) . Since verapamil decreased longer ERP values the effects of both verapamil and diltiazem in the presence without significantly affecting short ERPs, the drug sigof intact autonomic reflexes, conduction velocity was nificantly reduced ERP heterogeneity (Fig. 5C) .
unaffected by verapamil administration in the presence of Verapamil produced spatially variable changes in conautonomic blockade (Fig. 8left) . These results indicate an duction. The drug resulted in faster conduction in the right important role for autonomic reflexes in mediating the atrial superior and posterior free walls, but did not change electrophysiological changes observed after verapamil conduction speed in the right atrial appendage (Fig. 6left) .
administration. Diltiazem produced qualitatively similar When all observations in the right atrium were combined, changes to verapamil in sinus cycle length, arterial presverapamil reduced ERP from 12265 to 11464 ms and sure and PR interval in the presence of autonomic blocincreased conduction velocity from 9062 to 9963 cm / s kade (Table 3) , and similarly failed to alter AF duration. (P,0.02 for each). Because of the offsetting changes in Changes in conduction velocity after diltiazem administra- Fig. 6 . Effect of verapamil (0.2 mg / kg followed by 1.5 mg / kg / min, left panels) and diltiazem (0.8 mg / kg followed by 15 mg / kg / min, right panels) in the presence of intact autonomic tone on conduction velocity in each of three atrial regions.
tion in the presence of autonomic blockade are shown in 4. Discussion Fig. 8 (right panels) . As for verapamil, no significant changes in conduction were seen after diltiazem adminisWe have shown that verapamil promotes the maintetration when the experiment was conducted in the presence nance of AF in normal dogs. The underlying mechanism of b-adrenergic and muscarinic blockade.
appears to be a potentiation of multiple circuit reentry requiring intact autonomic function. Diltiazem did not dependent ERP adaptation being hallmark features [12] . 21 share the AF promoting action of verapamil in this model. Decreases in L-type Ca current seem to be central to these electrophysiological effects of tachycardia-induced 21 21 4.1. Role of L-type Ca currents and their blockade remodeling [13] . Ca overload due to an increased rate of in AF action potential generation may be important in initiating tachycardia-related remodeling, which may in part be a 21 L-type Ca current plays an important role in maintainprotective response of cardiomyocytes to prevent damage 21 ing the plateau of the atrial action potential and changes in caused by Ca loading [14] . Consistent with this concept, 21 Ca current are an important contributor to rate-depenverapamil prevents some of the changes caused by short dent adaptations in atrial action potential duration [10, 11] .
term (,24 h) atrial tachycardias [15] [16] [17] [18] ; however, L-type 21 Atrial tachycardias, including AF, modify atrial properties Ca channel blockers do not prevent remodeling by atrial to promote AF maintenance, with reduced ERP and ratetachycardias lasting a week or longer [5, 19] . Furthermore, dogs maintained on verapamil up to and during electrochanges caused by atrial tachycardia-induced remodeling 21 physiological study after a 7-day or greater period of atrial [13] , it would not be surprising for Ca channel blockers tachycardia have more sustained AF than control dogs [5] .
like verapamil to promote AF maintenance. The results of 21 Given the fact that reduced Ca current seems to be the present study do show that verapamil promotes AF; important in the AF-promoting atrial action potential however, a number of our findings argue against the simple notion that this action of verapamil is due to a mimicking AF. Alternatively, verapamil's actions on atrial activation of the changes caused by atrial tachycardia. First, atrial during AF may have resulted from presently unrecognized tachycardia-induced remodeling causes substantial deactions on impulse propagation during the arrhythmia, or creases in atrial ERP [12, 13] , whereas the decreases caused from other at present unrecognized actions. by verapamil in the present paper were relatively modest.
Verapamil has also been noted to have effects on Second, increased atrial ERP heterogeneity is a prominent ventricular fibrillation (VF). In isolated hearts, which by AF-promoting feature of tachycardia-induced remodeling definition lack reflex autonomic responses, verapamil in the dog [20, 21] , whereas ERP heterogeneity was decreases the complexity of fibrillatory activity [24, 25] . On reduced by verapamil. Third, if verapamil's AF-promoting the other hand, verapamil increases the frequency of 21 effects were due to L-type Ca channel blockade alone, ventricular fibrillatory activity in the in situ heart [26] . one would have expected them to be enhanced by bThese results are consistent with AF activation changes 21 adrenergic blockade, since the latter reduces L-type Ca seen respectively in the absence and presence of autonomic current; however, the opposite result (an elimination of AF blockade in the present study. They suggest that verpromotion) was seen in autonomically blocked dogs.
apamil's effects on AF and VF have some interesting 21 Finally, if Ca channel blockade was the primary mechasimilarities, which warrant more detailed analysis in nism of verapamil's AF-promoting properties, one might subsequent work. have expected to have observed similar phenomena with Although intact autonomic reflexes were required for diltiazem, particularly at doses (like the ones we used) that verapamil's AF-promoting actions, consistent with previcause comparable degrees of PR interval prolongation.
ous observations [6] , autonomic interactions alone were insufficient to explain the effects of verapamil. Vagal 4.2. Mechanism of verapamil's AF promoting properties enhancement is unlikely to have played any significant role, since increasing vagal tone substantially increases Verapamil promoted AF in the present study by increasatrial ERP heterogeneity [27] , the opposite of the changes ing the apparent number of reentry circuits during AF and seen with verapamil. Friedman et al. showed that the thereby stabilizing multiple circuit reentry. Precisely how AF-promoting effects of verapamil are prevented by bverapamil achieved this remains unclear. Although veradrenergic receptor blockade, pointing to an important role apamil did decrease atrial ERP, this effect was relatively for sympathetic stimulation [6] . Sympathetic enhancement small during 1:1 atrial pacing, and seems insufficient to is likely to have occurred during verapamil infusion, but explain the significant changes in atrial activation that increased sympathetic outflow itself has not been found to occurred during AF. Furthermore, verapamil accelerated have a significant AF-promoting effect in the normal dog conduction in several atrial regions, which counteracts the heart [27] . It is therefore likely that intact sympathetic effect of ERP reductions on wavelength, leaving the responses are necessary for verapamil's AF-promoting minimal reentrant circuit size apparently unchanged. It is action, but that in themselves sympathetic effects are possible that the regional variability of the conduction insufficient to account fully for this property of the drug. speeding effect of verapamil contributed to heterogeneous
The discrepancy between verapamil and diltiazem in activation during AF; however, this is unlikely to have AF-promoting properties is an interesting observation that been of prime importance, since diltiazem had similar requires explanation. Unlike verapamil, diltiazem did not effects on atrial conduction but did not promote AF. The decrease ERP or AF cycle length. Of note, diltiazem's abolition of conduction-speeding by both drugs with effects on atrial conduction were very similar to those of autonomic blockade suggests that this action was indirect, verapamil in both the presence and absence of autonomic quite possibly due to adrenergic enhancement.
tone (Figs. 6 and 8 ). Diltiazem's lack of AF-promoting We measured atrial ERP and conduction velocity during potential could be due to a different time and voltage 21 1:1 atrial pacing, and it is possible that these do not dependent profile of Ca channel blockade or to different necessarily reflect the drug's electrophysiological actions collateral properties. Further studies to clarify this issue, in at the very rapid rates of AF. Verapamil has complex both experimental and clinical settings, might be of 1 effects on a variety of K channels [22] , as well as rate considerable interest. 21 and voltage dependent blocking actions on L-type Ca 1 channels [23] . The K -channel inhibiting actions of the 4.3. Novel aspects and potential clinical relevance drug may explain its effect to prolong ERP in the present study when adrenergic reflexes were absent in auVerapamil's AF promoting action has been reported tonomically-blocked dogs. The rate dependent effects of clinically [4] and in an experimental model [6] . Neither 1 21 verapamil on various K and Ca channels, the varying publication addressed potential underlying electrophysioimportance of each channel during the action potential logical mechanisms. Friedman et al. did show that betaplateau at different rates, and varying degrees of adrenergic adrenoceptor blockade prevents AF promotion by verreflex activity at different heart rates may have resulted in apamil, but did not examine electrophysiological changes. much smaller ERP changes at slower 1:1 rates than during
In the present study, we show that verapamil promotes AF
